Loading clinical trials...
Loading clinical trials...
A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
Conditions
Interventions
UCAR T-cell
Locations
1
China
Children's Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Start Date
December 1, 2025
Primary Completion Date
December 1, 2028
Completion Date
December 1, 2029
Last Updated
February 3, 2026
NCT06948110
NCT06342713
NCT07408336
NCT07275736
NCT06575426
NCT07040774
Lead Sponsor
The Children's Hospital of Zhejiang University School of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions